VIEMED HEALTHCARE, INC. Quarterly Debt-to-equity in % from Q4 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Viemed Healthcare, Inc. quarterly Debt-to-equity history and growth rate from Q4 2018 to Q3 2024.
  • Viemed Healthcare, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 34.8 %, a 10.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 34.8 +3.19 +10.1% Sep 30, 2024
Q2 2024 35.6 +6.56 +22.6% Jun 30, 2024
Q1 2024 37.2 +13 +54% Mar 31, 2024
Q4 2023 35.3 +11.3 +47.3% Dec 31, 2023
Q3 2023 31.6 +6.66 +26.7% Sep 30, 2023
Q2 2023 29 +3.58 +14.1% Jun 30, 2023
Q1 2023 24.1 -2.33 -8.81% Mar 31, 2023
Q4 2022 24 -5.31 -18.1% Dec 31, 2022
Q3 2022 24.9 -7.72 -23.6% Sep 30, 2022
Q2 2022 25.4 -12.6 -33.1% Jun 30, 2022
Q1 2022 26.5 -18.6 -41.3% Mar 31, 2022
Q4 2021 29.3 -24.5 -45.5% Dec 31, 2021
Q3 2021 32.7 -33 -50.2% Sep 30, 2021
Q2 2021 38 -39.3 -50.9% Jun 30, 2021
Q1 2021 45 -44.6 -49.7% Mar 31, 2021
Q4 2020 53.7 -36 -40.1% Dec 31, 2020
Q3 2020 65.6 -18.7 -22.1% Sep 30, 2020
Q2 2020 77.3 +2.36 +3.15% Jun 30, 2020
Q1 2020 89.6 +24.1 +36.7% Mar 31, 2020
Q4 2019 89.8 +26.7 +42.4% Dec 31, 2019
Q3 2019 84.3 Sep 30, 2019
Q2 2019 74.9 Jun 30, 2019
Q1 2019 65.6 Mar 31, 2019
Q4 2018 63 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.